NCT04597944View on ClinicalTrials.gov

Lanadelumab in Bradykinin Angioedema

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 18, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Angioedema
Trial Locations (2)

38043

RECRUITING

Chu Grenoble Alpes, Grenoble

Unknown

RECRUITING

CHU Rouen, Rouen

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT04597944 - Lanadelumab in Bradykinin Angioedema | Biotech Hunter | Biotech Hunter